T cell-directed immunotherapy

T cell-directed immunotherapy has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 30, 2026: “Targeted nanoparticles resolved tissue scarring in mice”.

Intervention

1 paper studies itUpdated

1 new paper in 30 daysSee all 1

  • Animals1

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 paper in 12 months
Cancer Research

Targeted nanoparticles resolved tissue scarring in mice

In mouse experiments, targeted drug delivery restored lung and liver function, reduced toxicity and made liver and lung cancers more responsive to immunotherapy.In mouse experiments, targeted drug delivery restored lung and liver function, reduced toxicity and made liver and lung cancers more responsive to immunotherapy.

Mouse studyInterventions